Related Experiment Video
Updated: May 29, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Predictors of glycemic control among type 1 pediatric diabetes patients-Northeast Ethiopia
Hiwot Adege1, Gedefaw Getnet2, Abyou Seyfu Ambaye3
1School of Medicine, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Insights
Pediatric type 1 diabetes patients often have poor glycemic control. This highlights the need for targeted interventions to prevent long-term diabetes complications in children.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Pediatric Health
Background:
- Type 1 diabetes mellitus is a prevalent endocrine-metabolic disorder in children and adolescents globally.
- Effective management of pediatric type 1 diabetes is crucial for preventing long-term complications.
Purpose of the Study:
- To assess glycemic control levels in pediatric patients with type 1 diabetes.
- To identify predictors of glycemic control in this population.
Main Methods:
- A prospective cross-sectional study was conducted at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia.
- Data from 203 pediatric patients with type 1 diabetes were analyzed using bivariate and multivariate methods.
Main Results:
- Over half of the patients (52.7%) exhibited good glycemic control, while 47.3% had poor control.
- Factors associated with poor glycemic control included longer diabetes duration, comorbid conditions, and diabetes-related complications.
- Being a third-born child was also a significant factor.
Conclusions:
- Glycemic control is a significant challenge for pediatric patients with type 1 diabetes.
- These children require specialized attention to mitigate the long-term adverse effects of diabetes.
Introduction:
Type 1 diabetes mellitus is the most common endocrine-metabolic disorder in children and adolescents worldwide. This study aims to determine the metabolic glycemic control levels and predictors among pediatric type 1 diabetes patients.
Methods:
An institution-based prospective cross-sectional study was conducted from July 01, 2022 to October 30, 2022 among patients attending pediatric chronic follow-up at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia. Patients on follow-up for more than 3 months and aged under 18 years were enrolled in the study consecutively based on their visits. Data were entered into Epidata version 3.1 and exported to SPSS version 26 for analysis. Bivariate and multivariate analyses were done to identify the factors affecting glycemic control.
Result:
Among 203 patients with type 1 diabetes, the average age was 8.72 ± 4.25 years, with the largest group of participants being over 10 years old (77 patients, 37%). The majority of the patients were female, totaling 126 (62.1%), and about 69 (34.0%) were in grades 7-10. Retinopathy, nephropathy, and diabetic ketoacidosis were commonly observed diabetic-related complications in this study. More than half of the patients, 107 (52.7%), had good diabetic control, while 96 (47.3%) had poor diabetic control. Factors significantly associated with poor glycemic control include having diabetes for more than 5 years (aOR: 1.45; 95% CI: 0.47, 0.91), being a third-born child (aOR: 0.22; 95% CI: 0.05, 0.92), having a comorbid disease condition (aOR: 1.84; 95% CI: 0.29, 0.92), and experiencing diabetes-related complications (aOR: 0.26; 95% CI: 0.08, 0.97).
Conclusion:
The study found that glycemic control is significantly poor among pediatric patients with type 1 diabetes. As a result, these patients require special attention to prevent the long-term consequences of diabetes.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...